Has Amanda Gray received payments from drug or device companies?

Yes. Drug and device makers reported $2,202 in general payments to Amanda Gray across 118 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amanda Gray did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amanda Gray come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amanda Gray

Family · Greenville, SCNPI 1497429724

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 42.2% of the total. Reporting peaked in 2022 at $1,030 and has fallen 82.9% since, to $176 in 2025.

$2,202in general payments, 2019–2025

Across 118 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$930
Myovant Sciences Inc.$317
Galderma Laboratories, L.p.$133
Therapeuticsmd, Inc.$123
Pfizer$102
Scynexis, Inc.$73
plus $525 from 17 others

What the payments were for

Food & beverage$2,202100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	54	$930
Myovant Sciences Inc.	17	$317
Galderma Laboratories, L.p.	2	$133
Therapeuticsmd, Inc.	7	$123
Pfizer	5	$102
Scynexis, Inc.	4	$73
Currax Pharmaceuticals LLC	4	$54
Biohaven Pharmaceutical Holding Company Ltd.	3	$51
Avion Pharmaceuticals	2	$50
Takeda Pharmaceuticals U.S.A., Inc.	2	$44
Exeltis, USA Inc.	2	$38
Biohaven Pharmaceuticals, Inc.	2	$37
Agile Therapeutics, Inc.	2	$35
Tarsus Pharmaceuticals, Inc.	1	$35
Daiichi Sankyo Inc.	2	$32
Coloplast	2	$29
Bausch & Lomb Americas Inc.	1	$22
Astellas Pharma US Inc	1	$21
Mylan Pharmaceuticals Inc.	1	$19
Evofem Biosciences, Inc.	1	$16
Virtus Pharmaceuticals LLC	1	$16
Amgen	1	$14
Organon	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX$126
MYFEMBREE$116
VRAYLAR$114

How this compares

$2,202 in reported general payments places this provider in the 80th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina →

Other family in Greenville

Sara ChristieGreenville$229K
Carrie HendersonGreenville$91K
Michelle StrongGreenville$55K
Melissa BrownlowGreenville$20K
Sarah McNightGreenville$15K
Melissa MotesGreenville$13K
Matthew KeatonGreenville$10K
Kara Cooper GilmerAnderson$127K
Jessica BellEasley$96K
Sarah ValerioGreer$76K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →